STOCKHOLM, March 17, 2025 /PRNewswire/ --BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the US FDA Office of Orphan Products Development (OOPD) has granted orphan drug ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback